Citigroup
BTAL icon

Citigroup’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Citigroup’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,414
Closed -$66K – 7065
2014
Q2 		$66K Hold
3,414
– – ﹤0.01% 4957
2014
Q1 		$65K Sell
3,414
-906
-21% -$17.2K ﹤0.01% 5314
2013
Q4 		$83K Buy
4,320
+906
+27% +$17.6K ﹤0.01% 5381
2013
Q3 		$67K Sell
3,414
-140
-4% -$2.81K ﹤0.01% 5047
2013
Q2 		$75K Buy
+3,554
New +$76.3K ﹤0.01% 5079

Other funds holding BTAL

ICM
ICC Capital Management Orlando, Florida $760M AUM 17.03% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Citigroup's BTAL Position: Q3 2014 in Review

Citigroup sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2014, closing a stake of 3,414 shares — an estimated $66K sold.

Citigroup first reported a position in BTAL in Q2 2013 and held it in 5 quarters. The position peaked at $83K in Q4 2013. 5 funds tracked by Wall St. Rank hold BTAL as of Q3 2014.

  • Citigroup reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2014 after selling out during the quarter.
  • Citigroup sold 3,414 AGF US Market Neutral Anti-Beta Fund shares in Q3 2014, an estimated $66K.
  • Citigroup first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2013 and held it in 5 quarters.
  • Citigroup's AGF US Market Neutral Anti-Beta Fund position peaked at $83K in Q4 2013.
  • 5 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2014.

Based on Citigroup's 13F filing for Q3 2014, filed 14 Nov 2014.